NASDAQ: TOIOncology Institute Inc Stock Ownership - Who owns Oncology Institute?
Insider buying vs selling
Have Oncology Institute Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark L. Pacala | Director | 2025-11-18 | 2,160 | $4.00 | $8.64kSell |
| Mark L. Pacala | Director | 2025-11-18 | 46,630 | $4.00 | $186.52kSell |
| Mark L. Pacala | Director | 2025-11-18 | 1,210 | $4.00 | $4.84kSell |
| M33 Growth I LP | Director | 2025-09-04 | 6,018,168 | $3.09 | $18.60MSell |
| M33 Growth I LP | Director | 2025-09-04 | 681,832 | $3.09 | $2.11MSell |
| Brad Hively | Director | 2025-08-19 | 20,221 | $4.06 | $82.10kSell |
| Richard A. Barasch | Director | 2025-06-17 | 311,128 | $2.62 | $813.60kSell |
| Richard A. Barasch | Director | 2025-06-17 | 679,224 | $1.20 | $813.71kBuy |
| M33 Growth I LP | Director | 2025-06-05 | 76,324 | $3.05 | $232.79kSell |
| M33 Growth I LP | Director | 2025-06-05 | 673,676 | $3.05 | $2.05MSell |
TOI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TOI insiders and whales buy or sell their stock.
TOI Shareholders
What type of owners hold Oncology Institute Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ravi Yang Sarin | 12.61% | 12,404,740 | $37.59M | Insider |
| Richard A. Barasch | 7.24% | 7,126,571 | $21.59M | Insider |
| M33 Growth I LP | 5.53% | 5,444,207 | $16.50M | Insider |
| Vanguard Group Inc | 4.62% | 4,545,245 | $13.77M | Institution |
| Blackrock Inc | 3.49% | 3,434,875 | $10.41M | Institution |
| Deerfield Management Company LP | 3.42% | 3,360,052 | $10.18M | Institution |
| James E. Flynn | 3.35% | 3,296,107 | $9.99M | Insider |
| Centerbook Partners LP | 2.75% | 2,704,650 | $8.20M | Institution |
| Balyasny Asset Management LP | 2.56% | 2,518,337 | $7.63M | Institution |
| Kanen Wealth Management LLC | 1.87% | 1,842,101 | $5.58M | Institution |
TOI vs Medical Care Facility Stocks
Oncology Institute Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.